Please enable Javascript to use all features and improve your user experience.
DGTI 2022
Programme
People
Search
EN
All people
Dr. Sandra Wienzek-Lischka
Sort by Type
Date
Redner
22/09/2022
13:30
–
14:00
25 Min.
5 Min.
Vortrag
VS-12-1
Nicht-invasive Behandlungsstrategien bei Hämolytischer Erkrankung beim Fetus und Neugeborenen
Speaker
22/09/2022
17:35
–
17:40
3 Min.
2 Min.
Poster
PS-2-14
Improvement of accuracy in noninvasive fetal genotyping of fetal
KEL
and
ITGB3
(HPA-1a) using single molecule consensus sequencing
21. Fetomaternale Inkompatibilität, 7. Immunhämatologie und Immunologische Grundlagen
Further involvements
22/09/2022
09:30
–
09:40
6 Min.
4 Min.
Abstractvortrag
VS-9-5
Anti-HPA-5b antibodies and foetal and neonatal alloimmune thrombocytopenia: Incidental association or cause and effect?
20. Pädiatrische Transfusionsmedizin, 21. Fetomaternale Inkompatibilität
22/09/2022
17:30
–
17:35
3 Min.
2 Min.
Poster
PS-2-13
Analysis of different anti-HPA-1a mediated platelet clearance and their inhibitors in whole blood by platelet suspension phagocytosis assay
21. Fetomaternale Inkompatibilität, 7. Immunhämatologie und Immunologische Grundlagen
22/09/2022
17:35
–
17:40
3 Min.
2 Min.
Poster
PS-2-14
Improvement of accuracy in noninvasive fetal genotyping of fetal
KEL
and
ITGB3
(HPA-1a) using single molecule consensus sequencing
21. Fetomaternale Inkompatibilität, 7. Immunhämatologie und Immunologische Grundlagen
22/09/2022
17:45
–
17:50
3 Min.
2 Min.
Poster
PS-2-16
Maternal human leukocyte antigen (HLA) class II genotype is not a predictor of immunization against HLA class I in neonates with suspected fetal/neonatal alloimmune thrombocytopenia (FNAIT)
21. Fetomaternale Inkompatibilität, 7. Immunhämatologie und Immunologische Grundlagen
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy